Anticancer multidrug resistance mediated by MRP1: recent advances in the discovery of reversal agents.
about
Role of MRP transporters in regulating antimicrobial drug inefficacy and oxidative stress-induced pathogenesis during HIV-1 and TB infectionsRecent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapiesTargeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance.The synthesis and characterization of cellular membrane affinity chromatography columns for the study of human multidrug resistant proteins MRP1, MRP2 and human breast cancer resistant protein BCRP using membranes obtained from Spodoptera frugiperdaABC multidrug transporters: structure, function and role in chemoresistance.One-pot pseudo three-component reaction of nitroketene-N,S-acetals and aldehydes for synthesis of highly functionalized hexa-substituted 1,4-dihydropyridines.Pharmacophore-based discovery of ligands for drug transporters.Alterations in P-Glycoprotein Expression and Function Between Macrophage Subsets.Harnessing drug resistance: using ABC transporter proteins to target cancer cells.Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins.Chalcogenopyrylium dyes as differential modulators of organic anion transport by multidrug resistance protein 1 (MRP1), MRP2, and MRP4Psorospermin structural requirements for P-glycoprotein resistance reversal.In vitro and in vivo modulation of ABCG2 by functionalized aurones and structurally related analogs.Nanomicellar paclitaxel increases cytotoxicity of multidrug resistant breast cancer cellsModeling kinetics of subcellular disposition of chemicals.Advancement of structure-activity relationship of multidrug resistance-associated protein 2 interactions.Structure-activity relationships of tariquidar analogs as multidrug resistance modulators.Synthesis of nanodiamond-daunorubicin conjugates to overcome multidrug chemoresistance in leukemia.Flavonoid-induced glutathione depletion: potential implications for cancer treatmentImportance of ABCC1 for cancer therapy and prognosis.MRP1 and its role in anticancer drug resistance.Effect of siRNA pre-Exposure on Subsequent Response to siRNA Therapy.ABCG2/BCRP: Specific and Nonspecific Modulators.Identification of xanthones as selective killers of cancer cells overexpressing the ABC transporter MRP1.(R)- and (S)-verapamil differentially modulate the multidrug-resistant protein MRP1.Cysteinyl Leukotriene Receptor 1/2 Antagonists Nonselectively Modulate Organic Anion Transport by Multidrug Resistance Proteins (MRP1-4).Imaging of activity of multidrug resistance-associated protein 1 in the lungs.Transporters in Drug Discovery
P2860
Q26781386-E7911DC1-63F4-425C-A711-CAE076BE0D09Q33730375-AC254FB1-A7A1-4E16-990D-BD09A36E9623Q33763765-AAC6D686-5DFC-4417-81F3-B84791375546Q33833252-08DEC54C-FAD4-4A80-90BE-DBBE15ED0E13Q34586418-6E4E0218-F9D7-4C49-AE26-339063E0354CQ35204016-9C5A0338-56B5-4DA2-A6C3-513C4E0AE737Q35594214-488C131B-F602-42C1-AE90-A55D15D455F8Q36081148-EA8B8773-D3B0-4D75-9595-E64F92C86C56Q36316764-36EF4A42-C01D-4E2C-814E-12E09E1B3240Q36525551-F5975D59-C7D3-4AD9-8A2D-A9D97E67A7FFQ36852514-0E4EF026-1CF1-4DCB-B983-A9D9F6905E1CQ36982551-68DF4D6C-3E4B-4F89-9EFF-BDA66A3AF224Q37070476-C623699A-3157-40D9-95F2-CB8F89F2A66EQ37124784-33BC80E8-693A-4CF8-863B-8C94EF76DD93Q37194304-ED0DC225-B79E-42C7-8624-4B50825E9684Q37507771-6646E3D7-FCDE-444A-A77B-40B11A33D5BEQ37510736-8C4EB437-D8B1-4153-8830-B1BA152C2A1FQ37549450-B26DB3E2-8FA3-47B5-ADF2-388F06CEBF12Q37698424-E1576AB2-748C-4EAB-BCA6-72B71B34D4D8Q38199535-40131330-1282-4A60-870C-A2CE89B53125Q38626237-7AA32467-27B4-4DA3-8E53-7D3A9F85534EQ38858347-B7622488-EED9-4851-AA7E-BE36B196E0F4Q39049159-FF760C07-8015-469C-965E-319089EDFC3DQ39531813-C1F9B136-C662-4C14-BF35-CD0B45B57470Q40103522-4E117A36-41A5-4C37-860E-8D4443522FD1Q45348897-063310C1-7DCA-4DC8-BD48-31710519054FQ51062500-C7B397BF-53DF-4821-A409-4B56337F22AEQ57684264-46F379CB-B222-41CC-B08F-EE9E1B1F47FE
P2860
Anticancer multidrug resistance mediated by MRP1: recent advances in the discovery of reversal agents.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Anticancer multidrug resistanc ...... discovery of reversal agents.
@ast
Anticancer multidrug resistanc ...... discovery of reversal agents.
@en
type
label
Anticancer multidrug resistanc ...... discovery of reversal agents.
@ast
Anticancer multidrug resistanc ...... discovery of reversal agents.
@en
prefLabel
Anticancer multidrug resistanc ...... discovery of reversal agents.
@ast
Anticancer multidrug resistanc ...... discovery of reversal agents.
@en
P2093
P2860
P356
P1476
Anticancer multidrug resistanc ...... discovery of reversal agents.
@en
P2093
Ahcène Boumendjel
Attilio Di Pietro
Doriane Trompier
Hélène Baubichon-Cortay
Thomas Perrotton
P2860
P304
P356
10.1002/MED.20032
P577
2005-07-01T00:00:00Z